# DAIT CLINICAL SITE MONITORING CENTER

> **NIH NIH N01** · PPD DEVELOPMENT LP · 2020 · $2,868,026

## Abstract

This contract provides comprehensive clinical site monitoring services for clinical research studies and clinical trials conducted by the Immune Tolerance Network (ITN) by ensuring compliance with federal regulations and the International Conference on Harmonization. In addition, the contract will provide services for other DAIT-supported, investigator-initiated clinical research studies and clinical trials

## Key facts

- **NIH application ID:** 10074431
- **Project number:** 272201200004C-P00030-9999-1
- **Recipient organization:** PPD DEVELOPMENT LP
- **Principal Investigator:** MARY GLESSNER
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $2,868,026
- **Award type:** —
- **Project period:** 2012-01-01 → 2021-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10074431

## Citation

> US National Institutes of Health, RePORTER application 10074431, DAIT CLINICAL SITE MONITORING CENTER (272201200004C-P00030-9999-1). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10074431. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
